Rezultaty - Gibson, Michael
- Rezultaty 1 - 20 Rezultaty od 46
- Idź do następnej strony
-
1
-
2
Acute Urography od Roylance, John, Gibson, Michael J., Davies, Peter
Wydane 1969Text -
3
-
4
-
5
-
6
-
7
-
8
-
9
Atrial Conduction Slows Immediately Before the Onset of Human Atrial Fibrillation: A Bi-Atrial Contact Mapping Study of Transitions to Atrial Fibrillation od Lalani, Gautam G., Schricker, Amir, Gibson, Michael, Rostamian, Armand, Krummen, David E., Narayan, Sanjiv M.
Wydane 2012Text -
10
Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes od Gomez-Casal, Roberto, Bhattacharya, Chitralekha, Ganesh, Nandita, Bailey, Lisa, Basse, Per, Gibson, Michael, Epperly, Michael, Levina, Vera
Wydane 2013Text -
11
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes od Xu, Xu Steven, Moore, Kenneth, Burton, Paul, Stuyckens, Kim, Mueck, Wolfgang, Rossenu, Stefaan, Plotnikov, Alexei, Gibson, Michael, Vermeulen, An
Wydane 2012Text -
12
A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcino... od Zahoor, Haris, Luketich, James D., Levy, Ryan M., Awais, Omar, Winger, Daniel G., Gibson, Michael K., Nason, Katie S.
Wydane 2014Text -
13
MUC2 Expression is an Adverse Prognostic Factor in Superficial Gastroesophageal Adenocarcinomas od Davison, Jon M., Ellis, Shane T., Foxwell, Tyler J., Luketich, James D., Gibson, Michael K., Kuan, Shih-Fan, Nason, Katie S.
Wydane 2013Text -
14
A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer od Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.
Wydane 2010Text -
15
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer od LaPelusa, Michael, Shen, Chan, Gillaspie, Erin A., Cann, Christopher, Lambright, Eric, Chakravarthy, A. Bapsi, Gibson, Michael K., Eng, Cathy
Wydane 2022Text -
16
The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults od Kennedy, Richard B., Simon, Whitney L., Gibson, Michael J., Goergen, Krista M., Grill, Diane E., Oberg, Ann L., Poland, Gregory A.
Wydane 2016Text -
17
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology od Haralambieva, Iana H., Gibson, Michael J., Kennedy, Richard B., Ovsyannikova, Inna G., Warner, Nathaniel D., Grill, Diane E., Poland, Gregory A.
Wydane 2017Text -
18
A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck od Yao, Min, Galanopoulos, Nicholas, Lavertu, Pierre, Fu, Pingfu, Gibson, Michael, Argiris, Athanassios, Rezaee, Rod, Zender, Chad, Wasman, Jay, Machtay, Mitchell, Savvides, Panos
Wydane 2014Text -
19
Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma od Yao, Min, Lavertu, Pierre, Savvides, Panayiotis, Woods, Charles, Fu, Pingfu, Gibson, Michael, Rezaee, Rod, Zender, Chad, Wasman, Jay, Sharma, Neelesh, Machtay, Mitchell
Wydane 2016Text -
20
Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma od Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
Wydane 2018Text